One case of surgical treatment of coagulation factor XI deficiency complicated with esophageal cancer: a case report.

Autor: Tian Y; Department of Cardiothoracic Surgery, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, 310000, China., Zheng Z; Department of Cardiothoracic Surgery, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, 310000, China., Song N; Department of Cardiothoracic Surgery, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, 310000, China., Wang J; Department of Cardiothoracic Surgery, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, 310000, China. hz4z11@sohu.com.
Jazyk: angličtina
Zdroj: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Feb 02; Vol. 19 (1), pp. 40. Date of Electronic Publication: 2024 Feb 02.
DOI: 10.1186/s13019-024-02494-4
Abstrakt: Background: Coagulation factor XI deficiency is an autosomal recessive hereditary disease with a low incidence. It usually occurs after surgery or trauma; Esophageal cancer is a common malignant tumor of the digestive tract in China. But so far, surgery-based comprehensive treatment of esophageal cancer still dominates.
Case Presentation: We report a case of an Asian patient with XI factor deficiency and lower esophageal squamous cell carcinoma who was admitted to our hospital recently. After active preoperative preparation, the operation was successfully performed, and there was no obvious abnormal bleeding during and after the operation.
Conclusions: Coagulation factor XI deficiency is a relatively rare disease, and patients with the disease will face a greater risk of bleeding during the perioperative period. The encouraging perioperative outcome enables us to have a deeper understanding of surgical treatment strategies for patients with Coagulation factor XI deficiency.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: